These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 22152243

  • 1. [Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].
    Liang PP, Guo JJ, Li QL, Luo Q, Shi XF, Huang AL.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):516-20. PubMed ID: 22152243
    [Abstract] [Full Text] [Related]

  • 2. Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy.
    Zhang Y, He S, Li QL, Guo JJ.
    Virus Res; 2013 Nov 06; 177(2):156-62. PubMed ID: 23968804
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
    Kim SS, Cho SW, Kim SO, Hong SP, Cheong JY.
    J Med Virol; 2013 Jan 06; 85(1):55-64. PubMed ID: 23096938
    [Abstract] [Full Text] [Related]

  • 5. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
    Ji FZ, Wang L, Yang BH, Zhao JJ, Liu F, Xue Y, Li T.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr 06; 20(4):280-4. PubMed ID: 22964149
    [Abstract] [Full Text] [Related]

  • 6. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
    Sayan M, Hülagü S, Akhan SC, Sentürk O, Meriç M, Cekmen M.
    Mikrobiyol Bul; 2009 Jul 06; 43(3):425-32. PubMed ID: 19795617
    [Abstract] [Full Text] [Related]

  • 7. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Mirandola S, Sebastiani G, Rossi C, Velo E, Erne EM, Vario A, Tempesta D, Romualdi C, Campagnolo D, Alberti A.
    Antiviral Res; 2012 Dec 06; 96(3):422-9. PubMed ID: 23026293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.
    Karatayli E, Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C.
    Antivir Ther; 2013 Dec 06; 18(1):77-85. PubMed ID: 22878399
    [Abstract] [Full Text] [Related]

  • 11. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.
    Liu F, Chen L, Yu DM, Deng L, Chen R, Jiang Y, Chen L, Huang SY, Yu JL, Gong QM, Zhang XX.
    Gut; 2011 Sep 06; 60(9):1269-77. PubMed ID: 21292683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
    Baldick CJ, Eggers BJ, Fang J, Levine SM, Pokornowski KA, Rose RE, Yu CF, Tenney DJ, Colonno RJ.
    J Hepatol; 2008 Jun 06; 48(6):895-902. PubMed ID: 18362040
    [Abstract] [Full Text] [Related]

  • 14. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX, Li J, Qiu LM, Luo YW, Chen YH, Ran Y.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep 06; 17(9):641-4. PubMed ID: 19785947
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
    Suzuki F, Toyoda J, Katano Y, Sata M, Moriyama M, Imazeki F, Kage M, Seriu T, Omata M, Kumada H.
    J Gastroenterol Hepatol; 2008 Sep 06; 23(9):1320-6. PubMed ID: 18554238
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of hepatitis virus B isolated from a multi-drug refractory patient.
    Wei C, Chong YT, Wen JZ, Li YW, Li G.
    Virus Res; 2011 Jan 06; 155(1):254-8. PubMed ID: 20970466
    [Abstract] [Full Text] [Related]

  • 19. Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.
    Villet S, Ollivet A, Pichoud C, Barraud L, Villeneuve JP, Trépo C, Zoulim F.
    J Hepatol; 2007 Mar 06; 46(3):531-8. PubMed ID: 17239478
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.
    Luo Q, Zhong Y, Yang Y, Xiong Q, Hu Z, Lu W, Huang P, Zhang N.
    J Med Virol; 2012 Oct 06; 84(10):1558-61. PubMed ID: 22930503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.